Pembrolizumab Bulk Immunological Product from Germany
Mixed preparation of pembrolizumab (Keytruda) monoclonal antibody for immunotherapy in melanoma and lung cancer. HTS 3002.14.0010 applies to this bulk mixed form containing the antibody with formulation excipients, not for retail. Used in clinical or manufacturing settings.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include monoclonal antibody sequence data and purity certificates to confirm classification
• Adhere to USP <1043> ancillary materials guidelines if excipients are novel
• Watch for reclassification if purity exceeds 95% and deemed 'unmixed' per chapter notes